CoChat

Impact of glucagon‐like peptide‐1 on endothelial function

Open access
Sjöholm, Å · 2009 · Diabetes, Obesity and Metabolism
Cited by 22

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Cardiovascular (CV) disease is the major cause of mortality and morbidity in individuals with diabetes. Individuals with diabetes often have a variety of factors such as hyperglycaemia, dyslipidaemia, hypertension, insulin resistance and obesity, which increase their risks of endothelial dysfunction and CV disease. The incretin hormones, such as glucagon‐like peptide‐1 (GLP‐1), induce the glucose‐dependent secretion of insulin, improve beta‐cell function and induce slowing of gastric emptying and feelings of satiety – which result in reduced food intake and weight loss. Therapeutic treatments targeting the incretin system, such as GLP‐1 receptor agonists, offer the potential to address beta‐cell dysfunction (one the underlying pathogenic mechanisms of type 2 diabetes), as well as the resulting hyperglycaemia. Initial evidence now suggests that incretins could have beneficial effects on endothelial function and the CV system through both indirect effects on the reduction of hyperglycaemia and direct effects mediated through GLP‐1 receptor–dependent and –independent mechanisms. If these initial findings are confirmed in larger clinical trials, GLP‐1 receptor antagonists could help to address the major CV risks faced by patients with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2009.01074.x

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 22

Metadata

Authors
Sjöholm, Å.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2009-10-29
Volume
11
Issue
s3
Pages
19-25
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2008337869
Cited by
22
References
21
FWCI
1.09
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of glucagon‐like peptide‐1 on endothelial function. https://app.cochat.ai/papers/10.1111/j.1463-1326.2009.01074.x
The paper
Sjöholm, Å. (2009). Impact of glucagon‐like peptide‐1 on endothelial function. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2009.01074.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.